|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1101 to 1200 out of 1952 for Cdkn2a

0.022s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
First Author: Zou ZV
Year: 2020
Journal: Sci Rep
Title: Genomic profiling of the transcription factor Zfp148 and its impact on the p53 pathway.
Volume: 10
Issue: 1
Pages: 14156
Publication
First Author: Buchstaller J
Year: 2012
Journal: Cancer Cell
Title: Tumorigenic cells are common in mouse MPNSTs but their frequency depends upon tumor genotype and assay conditions.
Volume: 21
Issue: 2
Pages: 240-52
Publication
First Author: Bondar T
Year: 2010
Journal: Cell Stem Cell
Title: p53-mediated hematopoietic stem and progenitor cell competition.
Volume: 6
Issue: 4
Pages: 309-22
Publication
First Author: Wendel HG
Year: 2006
Journal: Cancer Res
Title: Determinants of sensitivity and resistance to rapamycin-chemotherapy drug combinations in vivo.
Volume: 66
Issue: 15
Pages: 7639-46
Publication
First Author: Terzian T
Year: 2008
Journal: Genes Dev
Title: The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss.
Volume: 22
Issue: 10
Pages: 1337-44
Publication
First Author: Tomás-Loba A
Year: 2008
Journal: Cell
Title: Telomerase reverse transcriptase delays aging in cancer-resistant mice.
Volume: 135
Issue: 4
Pages: 609-22
Publication
First Author: International Cancer Genome Consortium PedBrain Tumor Project.
Year: 2016
Journal: Nat Med
Title: Recurrent MET fusion genes represent a drug target in pediatric glioblastoma.
Volume: 22
Issue: 11
Pages: 1314-1320
Publication
First Author: Schmitt CA
Year: 1999
Journal: Genes Dev
Title: INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.
Volume: 13
Issue: 20
Pages: 2670-7
Publication
First Author: Fisher GH
Year: 2001
Journal: Genes Dev
Title: Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes.
Volume: 15
Issue: 24
Pages: 3249-62
Publication
First Author: Williams TM
Year: 2004
Journal: J Biol Chem
Title: Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia.
Volume: 279
Issue: 23
Pages: 24745-56
Publication
First Author: Lu Y
Year: 2001
Journal: Mol Cell Biol
Title: Disruption of the Cockayne syndrome B gene impairs spontaneous tumorigenesis in cancer-predisposed Ink4a/ARF knockout mice.
Volume: 21
Issue: 5
Pages: 1810-8
Publication  
First Author: Schmitt CA
Year: 2000
Journal: Cold Spring Harb Symp Quant Biol
Title: DNA damage responses and chemosensitivity in the E mu-myc mouse lymphoma model.
Volume: 65
Pages: 499-510
Publication
First Author: Zhou J
Year: 2020
Journal: Biochem Biophys Res Commun
Title: Bmi-1 determines the stemness of renal stem or progenitor cells.
Volume: 529
Issue: 4
Pages: 1165-1172
Publication
First Author: Suh YA
Year: 2011
Journal: Cancer Res
Title: Multiple stress signals activate mutant p53 in vivo.
Volume: 71
Issue: 23
Pages: 7168-75
Publication
First Author: Kwon MC
Year: 2013
Journal: Mol Oncol
Title: Mouse models for lung cancer.
Volume: 7
Issue: 2
Pages: 165-77
Publication
First Author: Joseph NM
Year: 2008
Journal: Cancer Cell
Title: The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.
Volume: 13
Issue: 2
Pages: 129-40
Publication
First Author: Jin X
Year: 2012
Journal: Mol Cancer Res
Title: Inactivation of heat shock factor Hsf4 induces cellular senescence and suppresses tumorigenesis in vivo.
Volume: 10
Issue: 4
Pages: 523-34
Publication
First Author: Panattoni M
Year: 2008
Journal: J Exp Med
Title: Targeted inactivation of the COP9 signalosome impairs multiple stages of T cell development.
Volume: 205
Issue: 2
Pages: 465-77
Publication
First Author: Martín-Caballero J
Year: 2004
Journal: Oncogene
Title: Different cooperating effect of p21 or p27 deficiency in combination with INK4a/ARF deletion in mice.
Volume: 23
Issue: 50
Pages: 8231-7
Publication
First Author: Vafaie F
Year: 2014
Journal: Aging Cell
Title: Collagenase-resistant collagen promotes mouse aging and vascular cell senescence.
Volume: 13
Issue: 1
Pages: 121-30
Publication
First Author: Garcia-Diaz C
Year: 2023
Journal: Cell Rep
Title: Glioblastoma cell fate is differentially regulated by the microenvironments of the tumor bulk and infiltrative margin.
Volume: 42
Issue: 5
Pages: 112472
Publication
First Author: Gon S
Year: 2018
Journal: Haematologica
Title: Fit αβ T-cell receptor suppresses leukemogenesis of Pten-deficient thymocytes.
Volume: 103
Issue: 6
Pages: 999-1007
Publication
First Author: Weiss WA
Year: 2003
Journal: Cancer Res
Title: Genetic determinants of malignancy in a mouse model for oligodendroglioma.
Volume: 63
Issue: 7
Pages: 1589-95
Publication
First Author: Halaban R
Year: 1998
Journal: Oncogene
Title: Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.
Volume: 16
Issue: 19
Pages: 2489-501
Publication  
First Author: Sato S
Year: 2015
Journal: Nat Commun
Title: Ablation of the p16(INK4a) tumour suppressor reverses ageing phenotypes of klotho mice.
Volume: 6
Pages: 7035
Publication  
First Author: Patel AV
Year: 2016
Journal: EBioMedicine
Title: An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors.
Volume: 9
Pages: 110-119
Publication  
First Author: Sheikh BN
Year: 2017
Journal: Exp Hematol
Title: MOZ and BMI1 act synergistically to maintain hematopoietic stem cells.
Volume: 47
Pages: 83-97.e8
Publication
First Author: Bardeesy N
Year: 2006
Journal: Proc Natl Acad Sci U S A
Title: Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.
Volume: 103
Issue: 15
Pages: 5947-52
Publication
First Author: Monahan KB
Year: 2010
Journal: Oncogene
Title: Somatic p16(INK4a) loss accelerates melanomagenesis.
Volume: 29
Issue: 43
Pages: 5809-17
Publication  
First Author: Perez BA
Year: 2013
Journal: Front Oncol
Title: Assessing the radiation response of lung cancer with different gene mutations using genetically engineered mice.
Volume: 3
Pages: 72
Publication
First Author: Hambardzumyan D
Year: 2009
Journal: Transl Oncol
Title: Modeling Adult Gliomas Using RCAS/t-va Technology.
Volume: 2
Issue: 2
Pages: 89-95
Publication
First Author: Frank KM
Year: 2000
Journal: Mol Cell
Title: DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway.
Volume: 5
Issue: 6
Pages: 993-1002
Publication
First Author: Hernández-Porras I
Year: 2016
Journal: J Pathol
Title: K-Ras(V14I) -induced Noonan syndrome predisposes to tumour development in mice.
Volume: 239
Issue: 2
Pages: 206-17
Publication
First Author: Kadariya Y
Year: 2016
Journal: Cancer Prev Res (Phila)
Title: Inflammation-Related IL1β/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma.
Volume: 9
Issue: 5
Pages: 406-414
Publication
First Author: Jansen AJ
Year: 2012
Journal: Blood
Title: Desialylation accelerates platelet clearance after refrigeration and initiates GPIbα metalloproteinase-mediated cleavage in mice.
Volume: 119
Issue: 5
Pages: 1263-73
Publication
First Author: Shah M
Year: 2010
Journal: PLoS Genet
Title: A role for ATF2 in regulating MITF and melanoma development.
Volume: 6
Issue: 12
Pages: e1001258
Publication
First Author: Zhu H
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in gliomagenesis.
Volume: 106
Issue: 8
Pages: 2712-6
Publication
First Author: Page A
Year: 2017
Journal: Mol Cancer Res
Title: IKKβ-Mediated Resistance to Skin Cancer Development Is Ink4a/Arf-Dependent.
Volume: 15
Issue: 9
Pages: 1255-1264
Publication  
First Author: Piunti A
Year: 2014
Journal: Nat Commun
Title: Polycomb proteins control proliferation and transformation independently of cell cycle checkpoints by regulating DNA replication.
Volume: 5
Pages: 3649
Publication
First Author: Wang X
Year: 2020
Journal: J Cell Physiol
Title: The proinflammatory cytokines IL-1β and TNF-α modulate corneal epithelial wound healing through p16(Ink4a) suppressing STAT3 activity.
Volume: 235
Issue: 12
Pages: 10081-10093
Publication
First Author: Fufa TD
Year: 2015
Journal: Hum Mol Genet
Title: Genomic analysis reveals distinct mechanisms and functional classes of SOX10-regulated genes in melanocytes.
Volume: 24
Issue: 19
Pages: 5433-50
Publication
First Author: Tuncer E
Year: 2019
Journal: J Clin Invest
Title: SMAD signaling promotes melanoma metastasis independently of phenotype switching.
Volume: 129
Issue: 7
Pages: 2702-2716
Publication
First Author: Fragola G
Year: 2013
Journal: PLoS Genet
Title: Cell reprogramming requires silencing of a core subset of polycomb targets.
Volume: 9
Issue: 2
Pages: e1003292
Publication
First Author: Maund SL
Year: 2011
Journal: Cancer Res
Title: Interleukin-1α mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells.
Volume: 71
Issue: 15
Pages: 5276-86
Publication
First Author: Phillips JJ
Year: 2012
Journal: J Clin Invest
Title: Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma.
Volume: 122
Issue: 3
Pages: 911-22
Publication
First Author: Ortiz B
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis.
Volume: 111
Issue: 22
Pages: 8149-54
Publication
First Author: Caganova M
Year: 2013
Journal: J Clin Invest
Title: Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis.
Volume: 123
Issue: 12
Pages: 5009-22
Publication
First Author: Maitituoheti M
Year: 2020
Journal: Cell Rep
Title: Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma.
Volume: 33
Issue: 3
Pages: 108293
Publication
First Author: Shima H
Year: 2018
Journal: Blood
Title: Ring1A and Ring1B inhibit expression of Glis2 to maintain murine MOZ-TIF2 AML stem cells.
Volume: 131
Issue: 16
Pages: 1833-1845
Publication
First Author: Calés C
Year: 2008
Journal: Mol Cell Biol
Title: Inactivation of the polycomb group protein Ring1B unveils an antiproliferative role in hematopoietic cell expansion and cooperation with tumorigenesis associated with Ink4a deletion.
Volume: 28
Issue: 3
Pages: 1018-28
Publication  
First Author: Campagne C
Year: 2017
Journal: Cell Signal
Title: RACK1 cooperates with NRASQ61K to promote melanoma in vivo.
Volume: 36
Pages: 255-266
Publication
First Author: Delmas V
Year: 2007
Journal: Genes Dev
Title: Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development.
Volume: 21
Issue: 22
Pages: 2923-35
Publication
First Author: Kloosterman DJ
Year: 2024
Journal: Cell
Title: Macrophage-mediated myelin recycling fuels brain cancer malignancy.
Volume: 187
Issue: 19
Pages: 5336-5356.e30
Publication
First Author: Nakagawa T
Year: 2015
Journal: Mol Cell Biol
Title: S6 Kinase- and β-TrCP2-Dependent Degradation of p19Arf Is Required for Cell Proliferation.
Volume: 35
Issue: 20
Pages: 3517-27
Publication
First Author: Sotillo R
Year: 2001
Journal: Proc Natl Acad Sci U S A
Title: Invasive melanoma in Cdk4-targeted mice.
Volume: 98
Issue: 23
Pages: 13312-7
Publication
First Author: Jun HJ
Year: 2012
Journal: Oncogene
Title: Acquired MET expression confers resistance to EGFR inhibition in a mouse model of glioblastoma multiforme.
Volume: 31
Issue: 25
Pages: 3039-50
Publication
First Author: Muraguchi T
Year: 2011
Journal: Cancer Res
Title: NKX2.2 suppresses self-renewal of glioma-initiating cells.
Volume: 71
Issue: 3
Pages: 1135-45
Publication
First Author: Li A
Year: 2012
Journal: J Invest Dermatol
Title: Activated mutant NRas(Q61K) drives aberrant melanocyte signaling, survival, and invasiveness via a Rac1-dependent mechanism.
Volume: 132
Issue: 11
Pages: 2610-21
Publication
First Author: Uka R
Year: 2020
Journal: Oncogene
Title: Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth.
Volume: 39
Issue: 20
Pages: 4132-4154
Publication
First Author: Jacobsen JA
Year: 2020
Journal: J Immunol
Title: Ezh2 Represses Transcription of Innate Lymphoid Genes in B Lymphocyte Progenitors and Maintains the B-2 Cell Fate.
Volume: 204
Issue: 7
Pages: 1760-1769
Publication
First Author: Tormo D
Year: 2009
Journal: Cancer Cell
Title: Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells.
Volume: 16
Issue: 2
Pages: 103-14
Publication
First Author: Zhang F
Year: 2018
Journal: Cancer Res
Title: Nanoparticles That Reshape the Tumor Milieu Create a Therapeutic Window for Effective T-cell Therapy in Solid Malignancies.
Volume: 78
Issue: 13
Pages: 3718-3730
Publication
First Author: Yang F
Year: 2024
Journal: Sci Adv
Title: An immunosuppressive vascular niche drives macrophage polarization and immunotherapy resistance in glioblastoma.
Volume: 10
Issue: 9
Pages: eadj4678
Publication
First Author: Zhou Y
Year: 2010
Journal: Nat Biotechnol
Title: Chimeric mouse tumor models reveal differences in pathway activation between ERBB family- and KRAS-dependent lung adenocarcinomas.
Volume: 28
Issue: 1
Pages: 71-8
Publication
First Author: Yamashita M
Year: 2013
Journal: Biochem Biophys Res Commun
Title: Nucleostemin is indispensable for the maintenance and genetic stability of hematopoietic stem cells.
Volume: 441
Issue: 1
Pages: 196-201
Publication
First Author: Yeo AT
Year: 2022
Journal: Nat Immunol
Title: Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression.
Volume: 23
Issue: 6
Pages: 971-984
Publication
First Author: Woolfenden S
Year: 2009
Journal: Genesis
Title: A Cre/LoxP conditional luciferase reporter transgenic mouse for bioluminescence monitoring of tumorigenesis.
Volume: 47
Issue: 10
Pages: 659-66
Publication
First Author: Shi C
Year: 2014
Journal: Lab Invest
Title: Fibrogenesis in pancreatic cancer is a dynamic process regulated by macrophage-stellate cell interaction.
Volume: 94
Issue: 4
Pages: 409-21
Publication
First Author: Morton JP
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer.
Volume: 107
Issue: 1
Pages: 246-51
Publication
First Author: Rai K
Year: 2015
Journal: Cancer Discov
Title: Dual Roles of RNF2 in Melanoma Progression.
Volume: 5
Issue: 12
Pages: 1314-27
Publication  
First Author: Kfoury A
Year: 2018
Journal: EMBO J
Title: AMPK promotes survival of c-Myc-positive melanoma cells by suppressing oxidative stress.
Volume: 37
Issue: 5
Publication
First Author: Fry EA
Year: 2017
Journal: Int J Cancer
Title: Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu.
Volume: 140
Issue: 3
Pages: 495-503
Publication
First Author: Ueberham E
Year: 2015
Journal: Mol Cancer Res
Title: Global increase of p16INK4a in APC-deficient mouse liver drives clonal growth of p16INK4a-negative tumors.
Volume: 13
Issue: 2
Pages: 239-49
Publication
First Author: Hosseini M
Year: 2015
Journal: J Invest Dermatol
Title: Premature skin aging features rescued by inhibition of NADPH oxidase activity in XPC-deficient mice.
Volume: 135
Issue: 4
Pages: 1108-1118
Publication
First Author: Kan Q
Year: 2008
Journal: J Biol Chem
Title: Cdc6 determines utilization of p21(WAF1/CIP1)-dependent damage checkpoint in S phase cells.
Volume: 283
Issue: 26
Pages: 17864-72
Publication  
First Author: Shapiro MJ
Year: 2019
Journal: Front Cell Dev Biol
Title: NKAP Regulates Senescence and Cell Death Pathways in Hematopoietic Progenitors.
Volume: 7
Pages: 214
Publication
First Author: Aguilera KY
Year: 2014
Journal: Cancer Res
Title: Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma.
Volume: 74
Issue: 4
Pages: 1032-44
Publication
First Author: Zhang D
Year: 2008
Journal: Oncogene
Title: Aurora A overexpression induces cellular senescence in mammary gland hyperplastic tumors developed in p53-deficient mice.
Volume: 27
Issue: 31
Pages: 4305-14
Publication
First Author: Jongsma J
Year: 2008
Journal: Cancer Cell
Title: A conditional mouse model for malignant mesothelioma.
Volume: 13
Issue: 3
Pages: 261-71
Publication
First Author: Peyre M
Year: 2013
Journal: Oncogene
Title: Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation.
Volume: 32
Issue: 36
Pages: 4264-72
Publication
First Author: Grosso S
Year: 2021
Journal: Nat Commun
Title: The pathogenesis of mesothelioma is driven by a dysregulated translatome.
Volume: 12
Issue: 1
Pages: 4920
Publication  
First Author: Badhai J
Year: 2020
Journal: J Exp Med
Title: Combined deletion of Bap1, Nf2, and Cdkn2ab causes rapid onset of malignant mesothelioma in mice.
Volume: 217
Issue: 6
Publication
First Author: Hönnemann J
Year: 2012
Journal: PLoS One
Title: Miz1 is a critical repressor of cdkn1a during skin tumorigenesis.
Volume: 7
Issue: 4
Pages: e34885
Publication
First Author: Wang C
Year: 2018
Journal: Breast Cancer Res
Title: Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
Volume: 20
Issue: 1
Pages: 74
Publication
First Author: Dodd RD
Year: 2016
Journal: Oncogene
Title: Myogenic transcription factors regulate pro-metastatic miR-182.
Volume: 35
Issue: 14
Pages: 1868-75
Publication
First Author: Guerra C
Year: 2011
Journal: Cancer Cell
Title: Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence.
Volume: 19
Issue: 6
Pages: 728-39
Publication
First Author: Morton JP
Year: 2008
Journal: Am J Pathol
Title: Trp53 deletion stimulates the formation of metastatic pancreatic tumors.
Volume: 172
Issue: 4
Pages: 1081-7
Publication
First Author: Chung WJ
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: Kras mutant genetically engineered mouse models of human cancers are genomically heterogeneous.
Volume: 114
Issue: 51
Pages: E10947-E10955
Publication
First Author: Alvarez R
Year: 2013
Journal: Br J Cancer
Title: Stromal disrupting effects of nab-paclitaxel in pancreatic cancer.
Volume: 109
Issue: 4
Pages: 926-33
Publication
First Author: Zhang F
Year: 2021
Journal: J Bone Miner Res
Title: Disruption of Jmjd3/p16(Ink4a) Signaling Pathway Causes Bizarre Parosteal Osteochondromatous Proliferation (BPOP)-like Lesion in Mice.
Volume: 36
Issue: 10
Pages: 1931-1941
Publication
First Author: Gidekel Friedlander SY
Year: 2009
Journal: Cancer Cell
Title: Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras.
Volume: 16
Issue: 5
Pages: 379-89
Publication
First Author: Genovese G
Year: 2012
Journal: Cancer Discov
Title: microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma.
Volume: 2
Issue: 8
Pages: 736-49
Publication
First Author: Gore AJ
Year: 2014
Journal: J Clin Invest
Title: Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation.
Volume: 124
Issue: 1
Pages: 338-52
Publication
First Author: Ling J
Year: 2012
Journal: Cancer Cell
Title: KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma.
Volume: 21
Issue: 1
Pages: 105-20
Publication
First Author: Boquoi A
Year: 2015
Journal: Aging Cell
Title: Reversible cell cycle inhibition and premature aging features imposed by conditional expression of p16Ink4a.
Volume: 14
Issue: 1
Pages: 139-47
Publication
First Author: van der Weyden L
Year: 2016
Journal: J Pathol
Title: Cross-species models of human melanoma.
Volume: 238
Issue: 2
Pages: 152-65
Publication
First Author: Fasseu M
Year: 2007
Journal: Blood
Title: p16INK4A tumor suppressor gene expression and CD3epsilon deficiency but not pre-TCR deficiency inhibit TAL1-linked T-lineage leukemogenesis.
Volume: 110
Issue: 7
Pages: 2610-9
Publication
First Author: Guha M
Year: 2009
Journal: Cancer Res
Title: Endogenous tumor suppression mediated by PTEN involves survivin gene silencing.
Volume: 69
Issue: 12
Pages: 4954-8
Publication
First Author: Vengoji R
Year: 2021
Journal: J Exp Clin Cancer Res
Title: Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma.
Volume: 40
Issue: 1
Pages: 335
Publication
First Author: Kranc KR
Year: 2003
Journal: Mol Cell Biol
Title: Transcriptional coactivator Cited2 induces Bmi1 and Mel18 and controls fibroblast proliferation via Ink4a/ARF.
Volume: 23
Issue: 21
Pages: 7658-66